No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1168 |
4. Check minimum number of eventsNone |
1168 |
5. Include endpointsNone |
1168 |
6. Filter based on genotype QC (FinnGen only) |
1168 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D31
- Name in latin
- Neoplasma benignum conjunctivae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Conjunctiva
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Conjunctiva
- Benign neoplasm of eye and adnexa
- Benign neoplasm of eye and adnexa
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 9125 | 4799 | 4289 |
| Only index persons | 8425 | 4519 | 3906 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.13 | 0.14 | 0.12 |
| Only index persons | 0.16 | 0.17 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 46.75 | 47.84 | 45.62 |
| Only index persons | 46.86 | 48.15 | 45.37 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1168 | 687 | 481 |
| Unadjusted period prevalence (%) | 0.23 | 0.23 | 0.21 |
| Median age at first event (years) | 53.42 | 50.89 | 57.03 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1037
- Matched controls
- 10369
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
4503599627370496.0
323.0
907
*
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
990.1
309.1
288
*
CFA20
NOMESCO Finland
Biopsy of conjunctiva
344.2
122.0
121
*
22400
ICD-8 Finland
Benign neoplasm of eye, Conjunctivae
+∞
97.4
92
*
XCK10
NOMESCO Finland
Photography of fundus of eye
5.0
61.5
219
523
CBB30
NOMESCO Finland
Excision of lesion of eyelid
10.9
57.6
114
116
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
9.1
51.8
113
137
CF2S4
NOMESCO Finland
Photography of conjunctiva
98.4
43.1
47
5
2243A
ICD-9 Finland
Benign neoplasm of eye, Conjunctiva
+∞
40.9
39
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.3
34.0
491
2936
CBA10
NOMESCO Finland
Biopsy of eyelid
15.4
30.3
50
34
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.2
29.4
408
2346
3401
FHL
Removal of local modification or taking a specimen in the operating room
+∞
28.2
27
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.5
23.8
216
991
H00.1
ICD-10 Finland
Chalazion
5.2
22.9
73
149
H11.4
ICD-10 Finland
Other conjunctival vascular disorders and cysts
20.6
21.8
32
16
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
17.1
19.2
30
18
H04.10
ICD-10 Finland
Dry eye syndrome
2.7
17.8
133
543
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
86.4
15.6
17
*
ZXA00
NOMESCO Finland
Right side
1.9
15.3
297
1845
F29
ICPC
Eye symptom/complaint other
2.6
14.0
104
421
CBB00
NOMESCO Finland
Excision of chalazion
6.9
12.7
31
46
S01GX01
ATC
cromoglicic acid; ophthalmic
1.9
11.7
206
1224
WX002
NOMESCO Finland
Sedation and analgesia
1.8
11.4
211
1274
CD2S4
NOMESCO Finland
Photography of eye
12.0
11.4
20
17
H11.8
ICD-10 Finland
Other specified disorders of conjunctiva
20.3
11.1
16
8
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
43.8
10.9
13
*
H01.0
ICD-10 Finland
Blepharitis
2.7
10.8
72
276
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.1
10.7
122
612
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
111.1
10.4
11
*
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.7
10.4
72
280
S18
ICPC
Laceration/cut
1.6
10.1
402
2989
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.6
10.0
74
301
H11.9
ICD-10 Finland
Disorder of conjunctiva, unspecified
40.5
10.0
12
*
ZXA05
NOMESCO Finland
Left side
1.6
9.2
258
1753
WX110
NOMESCO Finland
Local anesthesy
1.5
9.1
670
5674
N17
ICPC
Vertigo/dizziness
2.0
9.0
117
618
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
10.8
8.8
16
15
A98
ICPC
Health maint/preventive medicine
2.2
8.8
982
9241
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
4.6
8.7
29
65
R03AC02
ATC
salbutamol; inhalant
1.5
8.6
506
4061
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
5.1
8.1
24
48
H02AB06
ATC
prednisolone; systemic
1.5
7.6
436
3451
CBB99
NOMESCO Finland
Other excision or destruction of lesion of eyelid
10.1
7.5
14
14
H11.0
ICD-10 Finland
Pterygium
7.2
7.5
17
24
CFD10
NOMESCO Finland
Repair of conjunctiva
80.6
7.4
8
*
D31.1
ICD-10 Finland
Benign neoplasm: Cornea
80.6
7.4
8
*
S21
ICPC
Skin texture symptom/complaint
1.8
7.3
119
681
H10.4
ICD-10 Finland
Chronic conjunctivitis
5.8
7.2
19
33
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
6.9
90
477
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
13.9
6.9
11
8
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
8.3
6.8
14
17
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
4.2
6.8
24
58
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
40.3
6.8
8
*
T15.1
ICD-10 Finland
Foreign body in conjunctival sac
4.7
6.7
21
45
H02.8
ICD-10 Finland
Other specified disorders of eyelid
12.3
6.6
11
9
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
6.6
254
1842
A02BC02
ATC
pantoprazole; systemic
1.4
6.5
610
5234
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.5
374
2941
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
6.5
391
3098
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
6.4
264
1937
XCX10
NOMESCO Finland
Other photography of eye
70.3
6.4
7
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
6.3
196
1352
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
6.2
319
2449
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
6.2
217
1536
ZXA10
NOMESCO Finland
Bilateral
1.6
6.2
170
1137
S82
ICPC
Naevus/mole
1.7
6.2
116
700
H33.0
ICD-10 Finland
Retinal detachment with retinal break
3.2
6.1
30
97
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
429
3288
1.48
9.06
3.3
3.4
2.4
2.4
mmol/l
0.50
369
2880
666
5565
1.46
8.93
10.1
8.9
3.9
4.1
e9/l
1.06
585
4884
841
7423
1.47
7.96
8.4
7.5
76.0
78.4
u/l
1.11
793
6962
973
8861
1.59
7.88
5.3
4.7
1.8
2.0
mu/l
0.78
893
8089
983
9045
1.55
6.83
15.9
13.1
80.5
80.9
ml/min/173m2
0.21
797
7441
486
3967
1.39
6.71
2.4
2.3
82.3
76.7
nmol/l
3.78
428
3542
502
4120
1.38
6.70
5.2
4.7
35.9
35.5
g/l
0.85
462
3822
395
3132
1.39
6.42
3.1
3.2
34.9
32.0
u/l
0.41
376
2985
594
5034
1.37
6.39
6.0
6.2
11.9
11.2
umol/l
0.48
557
4771
1119
10690
2.11
6.38
25.0
20.9
6.7
6.7
e9/l
0.01
1089
10396
1054
9896
1.67
6.29
19.2
16.5
4.0
4.0
mmol/l
0.43
1025
9621
1118
10689
2.07
6.16
24.9
20.9
4.5
4.5
e12/l
0.32
1086
10400
1118
10693
2.06
6.09
25.1
21.0
135.0
135.1
g/l
0.03
1099
10534
980
9066
1.50
6.07
4.1
3.9
1.3
1.3
mmol/l
0.43
880
8288
475
3909
1.36
6.05
2.2
2.0
96.6
94.9
pmol/l
0.34
239
2006
1117
10684
2.04
6.02
25.0
20.9
249.5
250.6
e9/l
0.22
1089
10420
338
2639
1.40
5.94
4.1
3.1
0.3
0.5
e6/l
0.85
251
2006
1028
9619
1.57
5.92
5.3
4.9
2.7
2.7
mmol/l
0.42
946
8848
797
7119
1.38
5.91
4.9
4.1
11.0
12.3
mm/h
2.14
738
6562
241
1774
1.45
5.88
3.1
3.0
2.5
2.4
mmol/l
0.30
216
1559
1013
9452
1.54
5.86
4.7
4.4
4.6
4.7
mmol/l
0.48
924
8755
1049
9869
1.62
5.81
19.1
16.4
139.7
139.7
mmol/l
0.00
1023
9611
823
7406
1.38
5.71
4.3
4.0
14.8
14.8
pmol/l
0.36
743
6733
1005
9393
1.50
5.43
4.6
4.3
1.5
1.5
mmol/l
0.23
915
8644
1025
9622
1.53
5.39
17.1
14.2
22.0
23.8
mg/l
1.08
813
7643
559
4775
1.33
5.34
7.2
6.8
1.2
1.2
mmol/l
0.70
473
4022
722
6400
1.34
5.32
5.5
4.5
42.3
2876.7
e6/l
2.07
15
97
516
4364
1.33
5.26
6.5
6.0
1.2
1.2
mmol/l
0.08
463
3946
1074
10203
1.65
5.22
12.2
10.4
25.5
25.8
u/l
0.25
1041
9853
216
1591
1.44
5.21
3.2
2.8
0.8
1.0
e6/l
1.16
124
906
149
1019
1.53
5.20
4.1
4.1
235.5
252.2
u/l
0.65
142
962
682
6026
1.32
4.97
3.1
3.0
—
—
—
0
0
715
6361
1.32
4.95
3.3
3.1
46.1
49.6
u/l
0.49
662
5958
264
2046
1.38
4.72
3.5
2.6
3.6
6.1
e6/l
4.23
234
1804
496
4226
1.30
4.60
3.3
2.7
122.6
122.3
ug/l
0.01
460
3896
435
3659
1.30
4.39
3.9
3.7
42.9
51.4
ng/l
0.19
288
2538
990
9314
1.41
4.32
4.9
4.5
5.9
5.9
mmol/l
0.20
902
8465
161
1166
1.44
4.23
2.1
2.2
222.2
128.2
ug/g
0.89
123
912
293
2343
1.33
4.23
2.3
2.3
—
—
—
0
0
340
2791
1.31
4.06
2.8
3.0
1323.5
1335.7
ng/l
0.02
292
2383
16
55
2.94
3.74
3.2
2.3
24.0
15.0
%
—
10
25
16
55
2.94
3.74
3.2
2.3
—
—
—
0
0
281
2283
1.30
3.56
1.6
1.5
20.5
20.7
nmol/l
0.10
238
1948
267
2159
1.31
3.50
1.7
1.7
0.9
1.1
mg/l
2.27
189
1649
303
2498
1.29
3.43
2.8
2.7
7768.0
6696.3
umol/l
0.13
271
2165
224
1782
1.32
3.30
2.0
1.7
1298.2
1190.6
nmol/l
0.50
165
1332
297
2454
1.28
3.29
2.4
2.1
3.0
3.0
mg/l
0.12
247
2089
360
3052
1.26
3.21
2.8
2.5
60.7
56.4
u/l
0.29
332
2837
92
633
1.49
3.18
2.3
2.5
12.0
16.2
au/ml
—
6
27
146
1099
1.38
3.10
3.1
2.7
6.7
8.2
umol/l
0.69
128
956
624
5635
1.23
3.09
5.1
4.9
6.6
6.7
mmol/l
0.65
581
5258
262
2160
1.27
2.93
1.3
1.3
1.9
1.6
u/ml
0.10
63
576
81
562
1.47
2.72
1.6
1.7
—
—
—
0
0
534
4788
1.21
2.71
4.6
3.7
0.0
0.0
estimate
0.80
99
884
928
8799
1.27
2.70
6.3
5.7
39.3
39.9
mmol/mol
1.28
862
8148
857
8056
1.24
2.68
21.4
17.2
13.7
13.7
%
0.30
848
7882
340
2915
1.23
2.68
2.1
2.1
194.1
233.6
u/l
0.33
315
2749
71
481
1.51
2.68
1.1
1.0
—
—
—
0
0
117
873
1.38
2.64
2.4
2.5
161.1
42.0
u/l
0.46
95
744
207
1680
1.28
2.61
1.5
1.5
—
—
—
0
0
525
4711
1.21
2.61
4.6
3.7
0.0
0.0
estimate
0.00
100
912
10
33
3.05
2.53
1.2
1.3
—
—
—
0
0
186
1496
1.29
2.52
3.4
2.9
2.8
2.4
e6/l
0.21
97
820
88
632
1.42
2.49
2.3
2.2
12.2
12.9
nmol/l
0.34
76
560
202
1647
1.27
2.46
1.3
1.3
31.7
33.3
iu/ml
0.06
60
533
160
1268
1.30
2.43
2.9
2.4
22.8
22.8
%
0.01
133
1079
83
595
1.43
2.38
2.4
3.3
4.3
4.6
pmol/l
1.86
75
519
275
2339
1.23
2.31
4.7
4.3
22.7
21.7
%
0.53
152
1096
206
1697
1.26
2.30
3.3
3.0
0.9
0.8
ug/l
0.17
142
1114
41
254
1.64
2.30
1.4
1.8
3.0
5.1
iu/l
1.01
14
83
523
4732
1.19
2.28
5.8
5.0
0.0
0.0
estimate
0.50
103
919
168
1356
1.28
2.22
2.7
2.4
2.4
2.3
g/l
0.26
161
1259
84
612
1.40
2.21
1.5
1.2
281.6
205.7
u/ml
0.37
78
556
301
2596
1.21
2.19
1.8
1.7
1.4
1.4
mmol/l
0.10
259
2185
181
1477
1.27
2.19
2.7
2.4
13.1
13.1
umol/l
0.04
169
1371
11
42
2.63
2.19
1.3
2.8
198.0
205.7
u/l
0.12
11
42
14
61
2.31
2.15
1.2
1.2
—
—
—
0
0
35
214
1.66
2.08
2.3
2.2
129.8
129.0
g/l
0.07
25
164
191
1586
1.24
2.00
1.8
1.8
—
—
—
0
0
91
685
1.36
1.99
1.7
1.6
—
—
—
0
0
35
217
1.63
1.99
2.0
1.6
—
—
—
0
0
329
2897
1.19
1.90
5.5
4.9
5.2
2.9
ug/l
0.47
297
2588
185
1540
1.24
1.90
3.0
3.4
0.8
0.8
mmol/l
0.34
171
1437
138
1114
1.27
1.85
1.7
1.8
—
—
—
0
0
41
270
1.54
1.83
1.6
1.3
—
—
—
0
0
293
2561
1.19
1.83
5.8
4.1
0.0
0.0
estimate
1.08
103
892
917
8789
1.20
1.83
19.5
15.2
39.5
39.8
%
0.34
691
6265
136
1103
1.26
1.76
1.7
1.8
—
—
—
0
0
10
41
2.45
1.75
1.1
2.3
—
—
—
0
0
238
2051
1.20
1.74
1.7
1.7
50000431.2
24926593.9
pmol/l
0.21
202
1693
135
1097
1.26
1.72
7.1
8.1
0.7
1.3
mmol/l
1.05
109
864
135
1099
1.26
1.70
7.0
8.1
5.1
5.1
kpa
0.01
127
1055
10
42
2.39
1.68
1.6
3.1
338.6
1427.0
u/ml
—
10
42
12
55
2.19
1.67
3.7
2.1
0.4
0.2
e9/l
1.20
12
49
6
19
3.17
1.66
1.2
1.0
51.9
24.0
u/ml
—
6
19
134
1099
1.25
1.59
7.0
8.1
12.4
12.2
kpa
0.25
127
1056
22
129
1.72
1.57
1.3
1.5
—
—
—
0
0
12
57
2.12
1.55
3.9
2.1
442.3
535.4
e6/l
0.40
12
49
147
1223
1.23
1.54
30.5
25.5
1.6
1.3
inr
0.97
14
159
18
100
1.81
1.53
1.2
1.2
—
—
—
0
0
11
51
2.17
1.51
1.1
1.0
—
—
—
0
0
78
602
1.32
1.50
2.8
3.7
1.6
2.0
mmol/l
0.24
55
460
14
72
1.96
1.49
1.0
1.4
—
17.4
—
0
14
43
301
1.44
1.48
1.7
1.7
—
—
—
0
0
98
783
1.27
1.46
2.7
3.0
204.3
210.5
ng/l
0.04
90
715
45
319
1.43
1.46
2.2
2.8
—
—
—
0
0
334
3009
1.15
1.41
3.5
3.1
7.1
7.6
mmol/l
0.96
278
2523
26
165
1.59
1.41
1.4
1.6
—
—
—
0
0
15
81
1.86
1.40
1.4
1.2
2.5
0.9
u/ml
—
8
34
12
60
2.01
1.38
1.1
1.2
—
—
—
0
0
5
17
2.95
1.36
1.2
1.2
—
—
—
0
0
0
40
0.00
1.32
0.0
1.5
—
—
—
0
0
93
750
1.26
1.31
2.0
2.7
69.2
66.1
ml/min/173m2
0.28
33
316
30
201
1.51
1.30
5.0
3.6
56.0
58.0
%
0.42
30
201
6
24
2.51
1.30
1.7
2.2
—
—
—
0
0
8
35
2.29
1.27
2.4
1.5
4.8
5.2
umol/l
—
8
35
133
1121
1.21
1.25
1.7
1.8
1.6
1.5
%
0.43
117
984
29
195
1.50
1.25
4.7
3.3
4.3
4.4
e9/l
0.04
29
195
6
25
2.41
1.24
1.2
1.0
—
—
—
0
0
94
765
1.25
1.23
1.9
3.2
65.3
66.8
g/l
1.62
87
701
110
911
1.23
1.23
2.5
2.3
0.2
0.2
g/l
0.67
105
856
23
147
1.58
1.23
1.3
1.5
—
—
—
0
0
40
288
1.40
1.22
1.5
1.5
299.1
281.6
ug/g
0.23
28
166
48
357
1.36
1.22
1.7
1.7
7.6
4.6
mg/l
0.27
33
268
181
1574
1.18
1.21
1.4
1.3
15.4
13.3
u/ml
0.13
68
610
22
140
1.58
1.20
1.1
1.2
4.1
5.9
u/ml
—
8
58
119
997
1.22
1.20
4.3
4.3
3.5
22.9
ug/l
1.61
98
822
13
73
1.79
1.11
1.8
1.3
0.9
1.0
g/l
1.33
13
73
8
41
1.96
1.09
3.0
4.1
—
—
—
0
0
20
128
1.57
1.09
1.5
1.6
—
—
—
0
0
26
177
1.48
1.08
1.1
1.2
279.6
269.8
u/ml
0.07
20
106
91
755
1.22
1.03
4.0
3.8
84.4
83.5
ng/l
0.04
75
665
49
377
1.31
1.03
1.4
1.4
28.7
29.6
iu/l
0.06
39
326
27
188
1.45
1.02
1.1
1.2
—
—
—
0
0
37
273
1.37
1.02
1.1
1.2
—
—
—
0
0
7
35
2.01
1.00
1.1
1.7
—
—
—
0
0
26
181
1.45
0.99
1.4
1.6
—
—
—
0
0
98
824
1.21
0.98
2.3
2.4
6.0
7.2
ug/l
0.42
82
724
5
23
2.18
0.98
1.0
1.3
—
—
—
0
0
10
54
1.86
0.96
1.3
1.6
—
—
—
0
0
10
54
1.86
0.96
1.3
1.6
—
—
—
0
0
31
225
1.39
0.95
1.4
1.7
—
—
—
0
0
11
185
0.59
0.94
1.7
1.6
—
—
—
0
0
33
243
1.37
0.93
1.3
1.4
10.3
10.5
u/l
0.02
24
198
44
341
1.30
0.90
1.3
2.9
3.1
3.2
g/l
0.29
39
276
488
4607
1.10
0.90
4.4
4.0
—
—
—
0
0
20
135
1.49
0.89
1.7
1.5
0.9
0.3
nmol/l
0.68
11
103
23
160
1.45
0.89
1.1
1.1
2.4
0.9
u/ml
—
10
63
105
899
1.18
0.88
2.5
2.1
359.0
373.6
nmol/l
0.30
95
830
142
1247
1.16
0.88
6.5
5.6
1.1
1.0
mmol/l
0.35
135
1150
37
281
1.33
0.87
1.3
1.3
251.6
254.7
miu/ml
0.01
16
135
35
264
1.34
0.87
1.1
1.1
0.6
7.8
u/ml
—
5
30
24
170
1.42
0.85
1.3
1.7
—
—
—
0
0
31
230
1.36
0.85
1.4
1.6
—
—
—
0
0
17
112
1.53
0.85
1.3
1.5
—
—
—
0
0
32
239
1.35
0.85
1.4
1.3
—
—
—
0
0
8
46
1.74
0.82
1.3
1.2
—
—
—
0
0
8
46
1.74
0.82
1.0
1.2
—
—
—
0
0
134
1181
1.15
0.80
7.1
6.9
—
—
—
0
0
43
339
1.28
0.80
1.3
2.8
10.0
10.4
g/l
0.23
38
294
10
58
1.73
0.79
1.6
1.5
12.4
9.0
u/l
—
5
28
318
2956
1.10
0.79
4.5
4.0
7.7
9.1
mg/mmol
0.31
207
1867
390
3663
1.10
0.78
5.0
3.9
—
—
—
0
0
6
34
1.77
0.76
1.0
1.7
—
—
—
0
0
6
34
1.77
0.76
1.3
1.6
—
—
—
0
0
6
34
1.77
0.76
1.0
1.7
—
—
—
0
0
27
201
1.35
0.75
2.8
2.5
16.4
16.0
%
0.14
17
106
67
561
1.21
0.74
2.5
1.9
—
—
—
0
0
15
219
0.68
0.73
4.3
3.3
1.4
1.6
mmol/l
0.35
15
214
31
237
1.32
0.73
3.1
2.9
7.9
8.1
kpa
0.26
31
217
7
39
1.80
0.72
1.7
1.4
—
—
—
0
0
9
56
1.61
0.72
1.1
1.2
—
—
—
0
0
9
56
1.61
0.72
1.2
1.2
27.9
15.4
u/l
—
9
49
9
56
1.61
0.72
1.1
1.3
—
—
—
0
0
7
41
1.71
0.70
1.0
1.1
1036.0
1862.0
miu/ml
—
7
41
9
58
1.56
0.70
1.2
1.2
77.7
79.5
u/l
—
9
51
167
1511
1.12
0.69
1.5
1.4
—
—
—
0
0
227
2090
1.11
0.69
5.0
4.1
1.0
1.0
kg/l
0.38
28
306
34
266
1.29
0.69
1.4
1.3
—
—
—
0
0
16
110
1.46
0.68
1.4
1.7
—
—
—
0
0
5
27
1.86
0.68
1.0
1.3
—
—
—
0
0
5
27
1.86
0.68
1.0
1.2
—
—
—
0
0
7
42
1.67
0.68
2.0
2.0
9.8
220.0
ug/l
—
7
35
133
1189
1.13
0.67
4.4
4.4
31.7
32.3
%
0.23
80
799
7
43
1.63
0.67
1.1
1.5
—
1224630.0
—
0
5
26
197
1.33
0.66
1.0
1.4
—
—
—
0
0
26
197
1.33
0.66
1.0
1.4
—
—
—
0
0
27
206
1.32
0.66
1.5
1.4
—
—
—
0
0
27
206
1.32
0.66
1.5
1.4
—
—
—
0
0
27
206
1.32
0.66
1.5
1.4
—
—
—
0
0
27
206
1.32
0.66
1.5
1.4
—
—
—
0
0
7
44
1.59
0.65
1.1
1.2
—
—
—
0
0
7
44
1.59
0.65
1.1
1.2
—
—
—
0
0
10
62
1.62
0.65
1.3
1.5
—
—
—
0
0
10
62
1.62
0.65
1.6
2.3
—
—
—
0
0
47
386
1.23
0.65
1.6
1.9
—
—
—
0
0
39
314
1.25
0.64
1.8
1.8
—
—
—
0
0
95
834
1.15
0.63
6.5
7.2
8.7
9.8
mmol/l
1.02
90
791
6
103
0.58
0.62
1.5
1.2
—
—
—
0
0
44
361
1.23
0.62
1.3
2.8
3.9
3.8
g/l
0.49
39
271
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
49
1.64
0.62
1.0
1.3
—
—
—
0
0
5
30
1.67
0.61
1.4
1.6
—
—
—
0
0
44
362
1.22
0.61
1.3
2.8
7.4
7.4
g/l
0.02
39
278
44
362
1.22
0.61
1.3
2.8
—
—
—
0
0
18
131
1.38
0.59
1.1
1.0
1.5
2.1
u/ml
—
7
57
10
64
1.57
0.58
1.7
1.2
—
—
—
0
0
197
1822
1.10
0.56
3.5
3.8
751.4
350.5
ng/l
0.45
150
1406
53
450
1.19
0.55
2.2
1.7
—
—
—
0
0
6
38
1.58
0.54
1.0
1.3
—
—
—
0
0
20
151
1.33
0.54
1.2
1.2
—
—
—
0
0
76
666
1.15
0.54
1.3
1.2
221.9
138.7
iu/ml
0.64
30
261
17
125
1.37
0.53
1.0
1.3
—
0.6
nmol/l
—
0
7
17
125
1.37
0.53
1.1
1.1
—
—
—
0
0
31
382
0.81
0.53
1.7
1.9
2.1
2.3
ug/l
0.04
26
336
65
564
1.16
0.53
1.4
1.5
—
—
—
0
0
9
63
1.43
0.52
1.4
1.4
—
—
—
0
0
34
278
1.23
0.51
1.4
1.2
—
—
—
0
0
13
92
1.42
0.50
1.2
1.7
—
—
—
0
0
29
234
1.25
0.50
1.8
1.7
7280.1
14073.3
e6/l
1.17
24
178
37
307
1.21
0.49
1.6
1.6
0.0
20.8
iu/ml
—
6
58
14
101
1.39
0.49
1.1
1.1
—
—
—
0
0
12
84
1.43
0.49
1.3
1.2
—
—
—
0
0
16
119
1.35
0.48
1.6
1.4
—
—
—
0
0
11
76
1.45
0.48
1.0
1.0
327.6
280.2
mg/l
0.89
11
66
89
797
1.13
0.47
4.6
3.7
1.2
1.2
mmol/l
0.45
83
693
14
102
1.38
0.47
1.1
1.6
—
—
—
0
0
42
356
1.19
0.46
1.5
1.7
—
—
—
0
0
18
138
1.31
0.45
1.2
1.2
1.0
3.8
u/ml
—
6
41
16
209
0.76
0.45
1.4
1.6
—
—
—
0
0
16
121
1.33
0.44
1.2
1.6
46.5
58.3
%
0.63
11
85
34
284
1.20
0.44
3.0
4.2
2.4
1.8
ratio
—
7
27
19
148
1.29
0.43
1.2
1.1
—
—
—
0
0
11
78
1.41
0.43
1.4
1.6
—
—
—
0
0
33
276
1.20
0.42
1.4
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
0
17
0.00
0.40
0.0
2.1
—
0.9
—
0
11
27
224
1.21
0.38
1.6
1.5
—
—
—
0
0
9
66
1.37
0.38
1.1
1.6
11.9
13.2
umol/l
—
9
61
5
36
1.39
0.38
2.0
1.3
7.0
8.8
ug/l
—
5
36
87
793
1.10
0.37
1.6
1.7
—
—
—
0
0
9
122
0.74
0.35
1.2
1.4
—
—
—
0
0
9
122
0.74
0.35
1.2
1.4
—
—
—
0
0
17
135
1.26
0.35
1.1
1.1
—
—
—
0
0
9
123
0.73
0.35
1.2
1.3
—
—
—
0
0
9
123
0.73
0.35
1.2
1.4
—
—
—
0
0
9
125
0.72
0.35
1.2
1.3
—
—
—
0
0
9
125
0.72
0.35
1.2
1.4
—
—
—
0
0
10
73
1.37
0.34
1.4
1.1
—
—
—
0
0
10
73
1.37
0.34
1.4
1.1
—
—
—
0
0
6
45
1.34
0.33
1.0
1.6
—
—
—
0
0
6
45
1.34
0.33
1.0
1.6
—
—
—
0
0
6
45
1.34
0.33
1.0
1.6
—
—
—
0
0
6
45
1.34
0.33
1.0
1.6
—
—
—
0
0
27
318
0.85
0.33
1.9
2.1
17421.3
3468.2
u/l
—
7
136
31
266
1.17
0.32
1.3
1.5
—
—
—
0
0
10
74
1.35
0.32
1.4
1.1
—
—
—
0
0
10
74
1.35
0.32
1.4
1.1
—
—
—
0
0
10
74
1.35
0.32
1.4
1.1
—
—
—
0
0
35
305
1.15
0.31
1.5
1.4
—
—
—
0
0
26
221
1.18
0.30
1.1
1.5
136.4
664.7
e6/l
0.55
20
181
26
221
1.18
0.30
1.1
1.4
1.9
9.2
e6/l
1.48
19
176
16
129
1.24
0.30
1.1
1.1
116.8
115.4
%
0.07
16
120
17
139
1.23
0.29
1.5
1.6
—
—
—
0
0
11
85
1.30
0.28
2.9
1.1
—
—
—
0
0
10
128
0.78
0.27
3.4
2.8
106.0
105.4
mmol/l
—
10
128
5
71
0.70
0.26
1.0
1.0
—
—
—
0
0
5
72
0.69
0.26
1.0
1.1
200.4
237.6
mg/l
—
5
64
5
72
0.69
0.26
1.2
1.3
—
—
—
0
0
11
87
1.27
0.24
1.5
1.4
—
—
—
0
0
11
136
0.81
0.23
1.2
1.1
—
—
—
0
0
5
39
1.28
0.23
1.2
1.3
—
—
—
0
0
28
247
1.14
0.22
3.1
2.4
147.1
96.6
ug/min
0.23
20
150
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
17
144
1.18
0.22
3.5
5.3
372.8
366.0
umol/l
0.05
12
128
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
305
1.12
0.22
2.7
2.6
0.3
0.4
u/ml
0.90
19
165
5
42
1.19
0.21
1.8
2.4
49.4
47.9
umol/l
—
5
31
0
10
0.00
0.21
0.0
7.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
27
239
1.13
0.21
1.3
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
3.3
—
0.6
—
0
12
11
89
1.24
0.21
1.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
21
183
1.15
0.20
4.1
3.6
14.0
32.6
u/ml
2.11
21
178
6
51
1.18
0.19
1.2
1.2
—
—
—
0
0
23
259
0.89
0.18
1.1
1.2
—
—
—
0
0
30
332
0.90
0.18
1.5
1.8
—
—
—
0
0
54
506
1.07
0.16
1.7
1.3
—
—
—
0
0
10
84
1.19
0.14
1.1
1.5
—
—
—
0
0
10
84
1.19
0.14
1.1
1.5
—
—
—
0
0
10
84
1.19
0.14
1.1
1.5
—
—
—
0
0
33
306
1.08
0.13
1.4
1.4
—
—
—
0
0
10
85
1.18
0.12
2.7
2.3
—
—
—
0
0
30
279
1.08
0.11
1.9
1.6
—
—
—
0
0
14
157
0.89
0.11
1.2
1.5
—
—
—
0
0
5
47
1.06
0.09
1.0
1.6
—
—
—
0
0
5
47
1.06
0.09
1.0
1.2
176.6
519.8
u/l
—
5
41
12
134
0.89
0.08
1.3
1.1
—
—
—
0
0
6
58
1.03
0.08
1.3
1.7
2.0
6.0
u/field
—
6
41
6
73
0.82
0.07
1.2
1.3
—
—
—
0
0
9
86
1.05
0.07
1.0
1.0
—
—
—
0
0
8
93
0.86
0.06
2.0
2.5
—
—
—
0
0
104
1019
1.02
0.06
3.8
3.2
—
—
—
0
0
91
930
0.98
0.05
2.3
2.0
—
—
—
0
0
21
221
0.95
0.04
1.5
1.5
—
—
—
0
0
20
210
0.95
0.03
5.1
3.7
31.5
26.8
mg/l
0.24
12
131
14
131
1.07
0.03
1.1
1.0
—
—
—
0
0
101
1024
0.99
0.03
2.4
2.1
—
—
—
0
0
11
102
1.08
0.03
1.2
1.3
3.2
3.2
ug/l
0.01
11
87
22
212
1.04
0.02
1.2
1.3
—
—
—
0
0
87
877
0.99
0.01
4.4
3.6
1.7
2.0
mmol/l
0.39
76
700
17
168
1.01
0.00
1.3
1.6
—
—
—
0
0
22
221
1.00
0.00
1.2
1.5
—
—
—
0
0
10
97
1.03
0.00
1.1
1.1
96.5
94.6
%
—
10
89
41
413
0.99
0.00
1.5
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
10
100
1.00
0.00
3.0
3.8
—
—
—
0
0
62
620
1.00
0.00
7.5
7.6
25.0
24.6
mmol/l
0.49
57
579
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
7
69
1.01
0.00
2.1
1.6
—
—
—
0
0
8
81
0.99
0.00
1.6
1.7
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
0.00
2.0
2.2
—
266.5
—
0
8
0
7
0.00
0.00
0.0
1.6
—
12.7
—
0
7
5
55
0.91
0.00
1.2
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_CONJUNCTIVA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_CONJUNCTIVA | 0.859 [0.75, 0.98] | 0.028 |
| Birth year | 0.999 [0.99, 1.01] | 0.882 |
During the follow-up period (1.1.1998 — 31.12.2019), 382 out of 3763 females with CD2_BENIGN_CONJUNCTIVA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_CONJUNCTIVA | 0.942 [0.82, 1.08] | 0.393 |
| Birth year | 0.988 [0.98, 1.0] | 0.015 |
During the follow-up period (1.1.1998 — 31.12.2019), 471 out of 3295 males with CD2_BENIGN_CONJUNCTIVA died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_CONJUNCTIVA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.092% | 0.141% |
| 5 | 0.466% | 1.121% |
| 10 | 1.353% | 2.747% |
| 15 | 2.688% | 5.275% |
| 20 | 5.024% | 8.955% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CONJUNCTIVA – Benign neoplasm: Conjunctiva
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data